| PowerShares ETF Trust Dynamic Biotech & Genome Port | (NY: PBE) |
|
29.45 USD
-0.28 (-0.94%)
|
| View: | Quote | Chart | Options | News |
|
Fund Overview
Quote
Performance
|
Chart
Charting
Compare to:
|
Top News
More News
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company... Read More
from Market News Video
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company... Read More
from Market News Video
Grab KERX 7.9% Cheaper Than Its Secondary?
May 02, 2013
Looking back to 92 days ago, Keryx Biopharmaceuticals Inc. (KERX) priced a 8,234,000 share secondary stock offering at $8.49 per share. Read More
from Market News Video
Opko Health Enters Oversold Territory (OPK)
May 01, 2013
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a... Read More
from Market News Video
Bullish Two Hundred Day Moving Average Cross - LMNX
April 30, 2013
In trading on Tuesday, shares of Luminex Corp (LMNX) crossed above their 200 day moving average of $17.70, changing hands as high as $18.06 per share. Luminex Corp shares are currently trading up about... Read More
from Market News Video
PDL BioPharma Inc (PDLI) Shares Cross Below 200 DMA
April 17, 2013
In trading on Wednesday, shares of PDL BioPharma Inc (PDLI) crossed below their 200 day moving average of $7.32, changing hands as low as $7.31 per share. PDL BioPharma Inc shares are currently trading... Read More
from Market News Video
Myriad Genetics, Inc. (MYGN) Shares Cross Above 200 DMA
April 15, 2013
In trading on Monday, shares of Myriad Genetics, Inc. (MYGN) crossed above their 200 day moving average of $26.39, changing hands as high as $28.11 per share. Read More
from Market News Video
Under The Hood: An Unheralded Biotech ETF
April 11, 2013
Thursday's ETF Movers: PBE, PSCM
March 28, 2013
In trading on Thursday, the Dynamic Biotechnology & Genome Portfolio ETF (PBE) is outperforming other ETFs, up about 1.5% on the day. Components of that ETF showing particular strength include shares... Read More
from ETF Channel
Top Buys by Directors: Laukien's $1.4M Bet on BRKR
March 20, 2013
The directors of a company tend to have a unique inside view into the business, so when directors make major buys, investors are wise to take notice. Presumably the only reason a director of a company... Read More
from Market News Video
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here
